Open access · US-GOV via ClinicalTrials.gov Clinical trial

BETTER Aging Trial: Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB

Authors not listed

Posit Science Corporation · 2023

Dysbiosis Human Randomized controlled trial

Abstract

This study aims to examine the longer-term benefits of a novel, neuroplasticity-based, computerized and web-deliverable training program (PACR-CT) five years from the initial 10 weeks of training from our Phase II study - Protocol #: PSC-0605-17 (Aim 1) and test the interactive effect of previous training and 10 weeks of booster training (Aim 2). Both the study and the software being investigated meet the criteria of Non-Significant Risk.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-27 MST

Cite this

APA

Anonymous. (2023). BETTER Aging Trial: Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB. <em>Posit Science Corporation</em>. https://clinicaltrials.gov/study/NCT05599490

Vancouver

Anonymous. BETTER Aging Trial: Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB. Posit Science Corporation. 2023.

BibTeX

@misc{anon2023BETTER, title = {BETTER Aging Trial: Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB}, author = {Anonymous}, journal = {Posit Science Corporation}, year = {2023}, }